acetylcysteine and clozapine

acetylcysteine has been researched along with clozapine in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (31.58)29.6817
2010's8 (42.11)24.3611
2020's5 (26.32)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Lombardo, F; Obach, RS; Waters, NJ1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Gardner, I; Lai, WG; Uetrecht, JP; Zahid, N1
Jian, W; Yao, M; Zhang, D; Zhu, M1
Berk, M; Du Preez, JL; Emsley, R; Harvey, BH; Möller, M; Viljoen, FP1
Berk, M; Bush, AI; Castle, DJ; Conus, P; Copolov, D; Cuénod, M; Dean, OM; Do, KQ; Mancuso, SG; Rossell, SL1
Berk, M; Bozaoglu, K; Castle, DJ; Dark, F; Dean, O; Francis, PS; Galletly, C; Harris, A; Liu, D; Meyer, D; Neill, E; Phillipou, A; Rossell, SL; Sarris, J; Siskind, D1
Bolu, A; Çelik, C; Uzun, Ö1
Alexandre, J; Chrétien, B; Dolladille, C; Fedrizzi, S; Lelong-Boulouard, V; Sassier, M1
Beitler, JR; Dzierba, AL; Furfaro, D; Muir, J; Shah, J1
Berk, M; Bozaoglu, K; Castle, DJ; Dark, F; Dean, OM; Francis, PS; Galletly, C; Harris, A; Liu, D; Meyer, D; Neill, E; Phillipou, A; Rossell, SL; Sarris, J; Siskind, D; Yolland, C1
Andrade, C1

Reviews

3 review(s) available for acetylcysteine and clozapine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Use of N-Acetylcysteine for Clozapine-Induced Acute Liver Injury: A Case Report and Literature Review.
    Journal of pharmacy practice, 2023, Volume: 36, Issue:2

    Topics: Acetylcysteine; Chemical and Drug Induced Liver Injury; Clozapine; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Liver Failure, Acute; Middle Aged

2023
Antipsychotic Augmentation With N-Acetylcysteine for Patients With Schizophrenia.
    The Journal of clinical psychiatry, 2022, 09-26, Volume: 83, Issue:5

    Topics: Acetylcysteine; Antipsychotic Agents; Clozapine; Humans; Schizophrenia

2022

Trials

2 trial(s) available for acetylcysteine and clozapine

ArticleYear
N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms.
    BMC psychiatry, 2016, 09-15, Volume: 16, Issue:1

    Topics: Acetylcysteine; Adolescent; Adult; Aged; Antipsychotic Agents; Australia; Clozapine; Double-Blind Method; Drug Resistance; Female; Follow-Up Studies; Free Radical Scavengers; Humans; Male; Middle Aged; New Zealand; Quality of Life; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Young Adult

2016
N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms.
    Schizophrenia bulletin, 2022, 11-18, Volume: 48, Issue:6

    Topics: Acetylcysteine; Antipsychotic Agents; Australia; Clozapine; Double-Blind Method; Humans; Quality of Life; Schizophrenia; Treatment Outcome

2022

Other Studies

14 other study(ies) available for acetylcysteine and clozapine

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
Bioactivation and covalent binding of hydroxyfluperlapine in human neutrophils: implications for fluperlapine-induced agranulocytosis.
    Drug metabolism and disposition: the biological fate of chemicals, 2000, Volume: 28, Issue:3

    Topics: Acetylcysteine; Agranulocytosis; Binding, Competitive; Clozapine; Dibenzazepines; Glutathione; Hemocyanins; Humans; Hypochlorous Acid; Immune Sera; Immunoblotting; Neutrophil Activation; Neutrophils; Oxidation-Reduction; Peroxidase; Protein Binding

2000
Rapid detection and characterization of in vitro and urinary N-acetyl-L-cysteine conjugates using quadrupole-linear ion trap mass spectrometry and polarity switching.
    Chemical research in toxicology, 2009, Volume: 22, Issue:7

    Topics: Acetaminophen; Acetylcysteine; Analgesics, Non-Narcotic; Animals; Chromatography, High Pressure Liquid; Clozapine; Diclofenac; Glutathione; Humans; Microsomes, Liver; Rats; Tandem Mass Spectrometry

2009
Social isolation rearing induces mitochondrial, immunological, neurochemical and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine.
    Brain, behavior, and immunity, 2013, Volume: 30

    Topics: Acetylcysteine; Adenosine Triphosphate; Animals; Antipsychotic Agents; Behavior, Animal; Brain; Clozapine; Dopamine; Free Radical Scavengers; Kynurenine; Male; Maternal Deprivation; Memory; Mitochondria; Oxidative Stress; Rats; Rats, Sprague-Dawley; Social Behavior; Social Isolation

2013
Benefits of adjunctive N-acetylcysteine in a sub-group of clozapine-treated individuals diagnosed with schizophrenia.
    Psychiatry research, 2015, Dec-30, Volume: 230, Issue:3

    Topics: Acetylcysteine; Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Humans; Schizophrenia; Treatment Outcome

2015
Effect of N-acetylcysteine on clozapine-induced sialorrhea in schizophrenic patients: a case series.
    International clinical psychopharmacology, 2020, Volume: 35, Issue:4

    Topics: Acetylcysteine; Adult; Clozapine; Female; Humans; Male; Middle Aged; Schizophrenia; Sialorrhea

2020
Could N-acetylcysteine improve the safety of clozapine?
    Human psychopharmacology, 2021, Volume: 36, Issue:2

    Topics: Acetylcysteine; Antipsychotic Agents; Clozapine; Humans; Schizophrenia; Schizophrenia, Treatment-Resistant

2021